103 related articles for article (PubMed ID: 2807626)
1. Modulation of tumor necrosis factor activities by a potential anticachexia compound, hydrazine sulfate.
Hughes TK; Cadet P; Larned CS
Int J Immunopharmacol; 1989; 11(5):501-7. PubMed ID: 2807626
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.
Tracey KJ; Morgello S; Koplin B; Fahey TJ; Fox J; Aledo A; Manogue KR; Cerami A
J Clin Invest; 1990 Dec; 86(6):2014-24. PubMed ID: 2254457
[TBL] [Abstract][Full Text] [Related]
3. Contribution of tumor necrosis factor-alpha and glucocorticoid in hydrazine sulfate-mediated protection against endotoxin lethality.
Johnson DC; Freudenberg MA; Jia F; Gonzalez JC; Galanos C; Morrison DC; Silverstein R
Circ Shock; 1994 May; 43(1):1-8. PubMed ID: 7982269
[TBL] [Abstract][Full Text] [Related]
4. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary.
Silverstein R; Turley BR; Christoffersen CA; Johnson DC; Morrison DC
J Exp Med; 1991 Feb; 173(2):357-65. PubMed ID: 1988538
[TBL] [Abstract][Full Text] [Related]
5. Hydrazine sulfate: a current perspective.
Gold J
Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
[TBL] [Abstract][Full Text] [Related]
6. Metabolic responses to cachectin/TNF. A brief review.
Tracey KJ; Cerami A
Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578
[TBL] [Abstract][Full Text] [Related]
7. Transient exposure to tumor necrosis factor-alpha inhibits collagen accumulation by cultured hypertrophic scar fibroblasts.
Kitzis V; Engrav LH; Quinn LS
J Surg Res; 1999 Nov; 87(1):134-41. PubMed ID: 10527715
[TBL] [Abstract][Full Text] [Related]
8. Tumors secreting human TNF/cachectin induce cachexia in mice.
Oliff A; Defeo-Jones D; Boyer M; Martinez D; Kiefer D; Vuocolo G; Wolfe A; Socher SH
Cell; 1987 Aug; 50(4):555-63. PubMed ID: 3607879
[TBL] [Abstract][Full Text] [Related]
9. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
10. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
Broudy VC; Harlan JM; Adamson JW
J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
[TBL] [Abstract][Full Text] [Related]
11. Studies of cachexia in parasitic infection.
Tracey KJ; Cerami A
Ann N Y Acad Sci; 1989; 569():211-8. PubMed ID: 2698089
[TBL] [Abstract][Full Text] [Related]
12. The enhancement of human tumor necrosis factor-alpha antiviral activity in vivo by monoclonal and specific polyclonal antibodies.
Lidbury BA; Aston R; Ramshaw IA; Cowden WB; Rathjen DA
Lymphokine Cytokine Res; 1993 Apr; 12(2):69-74. PubMed ID: 8324079
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia.
Buck M; Houglum K; Chojkier M
Am J Pathol; 1996 Jul; 149(1):195-204. PubMed ID: 8686743
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumour necrosis factor and natural cytotoxic cell lytic activities by a spleen cell-elaborated factor.
Lin Y; Case PG; Patek PQ
Immunology; 1988 Apr; 63(4):663-8. PubMed ID: 3366472
[TBL] [Abstract][Full Text] [Related]
15. Effects of retinoic acid (vitamin A) on tumor necrosis factor cytolytic action.
Hughes TK; Fulep E
Biochem Biophys Res Commun; 1995 Jan; 206(1):223-9. PubMed ID: 7818524
[TBL] [Abstract][Full Text] [Related]
16. Bimodal effect of humic acids on the LPS-induced TNF-alpha release from differentiated U937 cells.
Junek R; Morrow R; Schoenherr JI; Schubert R; Kallmeyer R; Phull S; Klöcking R
Phytomedicine; 2009 May; 16(5):470-6. PubMed ID: 19131228
[TBL] [Abstract][Full Text] [Related]
17. The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factor.
Lidbury BA; Ramshaw IA; Rolph MS; Cowden WB
Arch Virol; 1995; 140(4):703-19. PubMed ID: 7794113
[TBL] [Abstract][Full Text] [Related]
18. Effects of lentinan on abnormal ingestive behaviors induced by tumor necrosis factor.
Tamura R; Tanebe K; Kawanishi C; Torii K; Ono T
Physiol Behav; 1997 Mar; 61(3):399-410. PubMed ID: 9089759
[TBL] [Abstract][Full Text] [Related]
19. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
Mahony SM; Beck SA; Tisdale MJ
Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
Quirk SM; Porter DA; Huber SC; Cowan RG
Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
